Edition:
India

Fate Therapeutics says FDA cleared third IND application for Fate-NK100​


Tuesday, 8 Aug 2017 

Aug 8 (Reuters) - Fate Therapeutics Inc ::Says ‍U.S. Food and Drug Administration cleared third Investigational New Drug (IND) application for Fate-NK100​. 

Company Quote

22.14
 --
15 Jul 2019